Key FInancial Inc - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 109 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
Key FInancial Inc ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$486
-74.1%
3,6850.0%0.00%
-100.0%
Q2 2023$1,879
-19.1%
3,6850.0%0.00%0.0%
Q1 2023$2,322
-63.4%
3,6850.0%0.00%
-66.7%
Q4 2022$6,338
+5.6%
3,6850.0%0.00%0.0%
Q3 2022$6,000
+20.0%
3,6850.0%0.00%0.0%
Q2 2022$5,000
+150.0%
3,6850.0%0.00%
+200.0%
Q1 2022$2,000
-50.0%
3,6850.0%0.00%
-50.0%
Q4 2021$4,000
-42.9%
3,6850.0%0.00%
-50.0%
Q3 2021$7,000
-12.5%
3,6850.0%0.00%0.0%
Q2 2021$8,000
-38.5%
3,6850.0%0.00%
-55.6%
Q1 2021$13,000
+44.4%
3,6850.0%0.01%
+28.6%
Q4 2020$9,0000.0%3,6850.0%0.01%
-22.2%
Q1 2020$9,0003,6850.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders